D Feldman-Stewart1, M D Brundage, L Van Manen. 1. Radiation Oncology Research Unit, Queen's University, Kingston, Ontario, Canada. deb.feldman-stewart@krcc.on.ca
Abstract
BACKGROUND: We developed a decision aid for patients with curable prostate cancer based on Svenson's DiffCon Theory of Decision Making. This study was designed to determine if surrogate patients using the aid could understand the information presented, complete all tasks, show evidence of differentiation, and arrive at a preferred treatment choice. METHODS: Men, at least 50 years old and never diagnosed with prostate cancer, were recruited through local advertisements. Participants were asked to imagine that they were a case-scenario patient. Then they completed the decision aid interview, which included three components: (i) information presentation, with comprehension questions, (ii) exercises to help identify attributes important to the decision, and (iii) value-clarification exercises. RESULTS: Sixty-nine men volunteered. They had a mean age of 61.2 (range 50-83) years, 37% had no formal education beyond high school, and 87% were living with a partner. All participants completed all aspects of the interview. They answered an average of 10 comprehension questions each, with a mean of 94.7% correct without a prompt. Each attribute in the information presented was identified by at least one participant as important to his decision. Participants identified a median of five attributes as important (ranges 1-14) at each of three points during the interview; 75% changed at least one important attribute during the interview. Forty-nine per cent of participants also identified attributes as important that were not included in the presented information. Participants showed a wide range of values in each of seven trade-off exercises. Eighty-eight per cent of participants showed evidence of differentiation; 75% had a clear treatment preference by the end of the interview. CONCLUSIONS: Our decision aid appears to meet its goals for surrogate patients and illustrates the strengths of the DiffCon theory. The ability of the aid to accommodate wide variability, both in information needs and in important attributes, is a particular strength of the decision aid. It now requires testing in patients with prostate cancer.
BACKGROUND: We developed a decision aid for patients with curable prostate cancer based on Svenson's DiffCon Theory of Decision Making. This study was designed to determine if surrogate patients using the aid could understand the information presented, complete all tasks, show evidence of differentiation, and arrive at a preferred treatment choice. METHODS:Men, at least 50 years old and never diagnosed with prostate cancer, were recruited through local advertisements. Participants were asked to imagine that they were a case-scenario patient. Then they completed the decision aid interview, which included three components: (i) information presentation, with comprehension questions, (ii) exercises to help identify attributes important to the decision, and (iii) value-clarification exercises. RESULTS: Sixty-nine men volunteered. They had a mean age of 61.2 (range 50-83) years, 37% had no formal education beyond high school, and 87% were living with a partner. All participants completed all aspects of the interview. They answered an average of 10 comprehension questions each, with a mean of 94.7% correct without a prompt. Each attribute in the information presented was identified by at least one participant as important to his decision. Participants identified a median of five attributes as important (ranges 1-14) at each of three points during the interview; 75% changed at least one important attribute during the interview. Forty-nine per cent of participants also identified attributes as important that were not included in the presented information. Participants showed a wide range of values in each of seven trade-off exercises. Eighty-eight per cent of participants showed evidence of differentiation; 75% had a clear treatment preference by the end of the interview. CONCLUSIONS: Our decision aid appears to meet its goals for surrogate patients and illustrates the strengths of the DiffCon theory. The ability of the aid to accommodate wide variability, both in information needs and in important attributes, is a particular strength of the decision aid. It now requires testing in patients with prostate cancer.
Authors: S Molenaar; M A Sprangers; F C Postma-Schuit; E J Rutgers; J Noorlander; J Hendriks; H C de Haes Journal: Med Decis Making Date: 2000 Jan-Mar Impact factor: 2.583
Authors: D Feldman-Stewart; M D Brundage; C Hayter; P Groome; J C Nickel; H Downes; W J Mackillop Journal: Med Decis Making Date: 2000 Jan-Mar Impact factor: 2.583
Authors: Donna L Berry; Barbara Halpenny; Fangxin Hong; Seth Wolpin; William B Lober; Kenneth J Russell; William J Ellis; Usha Govindarajulu; Jaclyn Bosco; B Joyce Davison; Gerald Bennett; Martha K Terris; Andrea Barsevick; Daniel W Lin; Claire C Yang; Greg Swanson Journal: Urol Oncol Date: 2011-12-07 Impact factor: 3.498
Authors: Deb Feldman-Stewart; Sarah Brennenstuhl; Kathryn McIssac; Joan Austoker; Agathe Charvet; Paul Hewitson; Karen R Sepucha; Tim Whelan Journal: Health Expect Date: 2007-03 Impact factor: 3.377
Authors: Deb Feldman-Stewart; Sarah Brennenstuhl; Michael D Brundage; D Robert Siemens Journal: Support Care Cancer Date: 2008-10-02 Impact factor: 3.603
Authors: Donna L Berry; Barbara Halpenny; Seth Wolpin; B Joyce Davison; William J Ellis; William B Lober; Justin McReynolds; Jennifer Wulff Journal: J Med Internet Res Date: 2010-12-17 Impact factor: 5.428
Authors: Maarten Cuypers; Romy Ed Lamers; Paul Jm Kil; Regina The; Klemens Karssen; Lonneke V van de Poll-Franse; Marieke de Vries Journal: Health Informatics J Date: 2017-07-27 Impact factor: 2.681
Authors: Rhodri Evans; Glyn Elwyn; Adrian Edwards; Eila Watson; Joan Austoker; Richard Grol Journal: J Med Internet Res Date: 2007-07-13 Impact factor: 5.428
Authors: Mirjam M Garvelink; Moniek M ter Kuile; Anne M Stiggelbout; Marieke de Vries Journal: BMC Med Inform Decis Mak Date: 2014-08-09 Impact factor: 2.796